CODX logo

Co-Diagnostics (CODX) EBIT

Annual EBIT

-$42.71 M
-$31.11 M-268.43%

December 31, 2023

Summary

Performance

1-Year Change

-268.43%

3-Year Change

-202.43%

5-Year Change

-595.9%

15-Year Change

-542.3%

CODX EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

38.1%
CODX annual earnings before interest & taxes is higher than 38.1% of companies in Healthcare sector

High & Low

All-time High

$46.06 M
CODX annual earnings before interest & taxes is currently -192.71% below its historical high of $46.06 million

3-Year Low

-$42.71 M
CODX annual earnings before interest & taxes is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
CODX previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 14, 2025
CODX next annual earnings announcement is scheduled for Mar 14, 2025

OtherCODXprofitabilitymetrics:

Annual Revenue

$6.81 M
CODX annual revenue is $6.81 million

Annual Net Income

-$35.33 M
CODX annual net profit is -$35.33 million

Annual EBITDA

-$41.48 M
CODX annual EBITDA is -$41.48 million

Annual EPS

-$1.20
CODX annual earnings per share is -$1.20

Quarterly EBIT

-$10.23 M
-$2.55 M-33.27%

September 30, 2024

Summary

Performance

3-Month Change

-33.27%

1-Year Change

+13.45%

3-Year Change

+13.45%

5-Year Change

+13.45%

CODX Quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

38.31%
CODX quarterly earnings before interest & taxes is higher than 38.31% of companies in Healthcare sector

High & Low

All-time High

$16.03 M
CODX quarterly earnings before interest & taxes is currently -163.85% below its historical high of $16.03 million

3-Year Low

-$11.99 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
CODX previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 14, 2025
CODX next earnings announcement is scheduled for Mar 14, 2025

OtherCODXprofitabilitymetrics:

Quarterly Revenue

$641.10 K
CODX quarterly revenue is $641.10 thousand

Quarterly Net Income

-$9.70 M
CODX quarterly net profit is -$9.70 million

Quarterly EBITDA

-$9.88 M
CODX quarterly EBITDA is -$9.88 million

Quarterly EPS

-$0.32
CODX quarterly earnings per share is -$0.32

TTM EBIT

-$40.00 M
-$1.30 M-3.36%

September 30, 2024

Summary

Performance

3-Month Change

-3.36%

1-Year Change

+6.34%

3-Year Change

+6.34%

5-Year Change

+6.34%

CODX TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

39.58%
CODX TTM earnings before interest & taxes is higher than 39.58% of companies in Healthcare sector

High & Low

All-time High

$53.11 M
CODX TTM earnings before interest & taxes is currently -175.31% below its historical high of $53.11 million

3-Year Low

-$43.02 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
CODX previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 14, 2025
CODX next earnings announcement is scheduled for Mar 14, 2025

OtherCODXprofitabilitymetrics:

TTM Revenue

$7.11 M
CODX TTM revenue is $7.11 million

TTM Net Income

-$41.28 M
CODX TTM net profit is -$41.28 million

TTM EBITDA

-$38.67 M
CODX TTM EBITDA is -$38.67 million

TTM EPS

-$1.38
CODX TTM earnings per share is -$1.38

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

Annual EBIT

-$42.71 M
CODX annual earnings before interest & taxes is -$42.71 million

Annual Revenue

$6.81 M
CODX annual revenue is $6.81 million

Annual Cost Of Goods Sold

$4.18 M
CODX annual cost of goods sold is $4.18 million

Annual Operating Expenses

$45.33 M
CODX annual total operating expenses is $45.33 million

CODX EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-268.4%+13.4%+6.3%
3 y3 years-202.4%+13.4%+6.3%
5 y5 years-595.9%+13.4%+6.3%

CODX EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-192.7%at low-199.3%+14.7%-186.8%+7.0%
5 y5-year-192.7%at low-163.8%+14.7%-175.3%+7.0%
alltimeall time-192.7%at low-163.8%+14.7%-175.3%+7.0%

Co-Diagnostics EBIT History

DateAnnualQuarterlyTTM
Sep 2024
-
-$10.23 M(+33.3%)
-$40.00 M(+3.4%)
Jun 2024
-
-$7.68 M(-25.1%)
-$38.70 M(-10.0%)
Mar 2024
-
-$10.26 M(-13.2%)
-$43.02 M(+0.7%)
Dec 2023
-$42.71 M(+268.4%)
-$11.83 M(+32.3%)
-$42.71 M(+2.6%)
Sep 2023
-
-$8.94 M(-25.5%)
-$41.61 M(+6.1%)
Jun 2023
-
-$11.99 M(+20.5%)
-$39.21 M(+25.0%)
Mar 2023
-
-$9.95 M(-7.3%)
-$31.37 M(+170.6%)
Dec 2022
-$11.59 M(-125.2%)
-$10.73 M(+64.2%)
-$11.59 M(-222.7%)
Sep 2022
-
-$6.54 M(+57.6%)
$9.45 M(-68.1%)
Jun 2022
-
-$4.15 M(-142.2%)
$29.62 M(-35.0%)
Mar 2022
-
$9.82 M(-4.7%)
$45.55 M(-1.1%)
Dec 2021
$46.06 M(+10.5%)
$10.31 M(-24.4%)
$46.06 M(-11.0%)
Sep 2021
-
$13.63 M(+15.6%)
$51.79 M(+3.2%)
Jun 2021
-
$11.79 M(+14.1%)
$50.19 M(-5.5%)
Mar 2021
-
$10.33 M(-35.5%)
$53.11 M(+27.4%)
Dec 2020
$41.69 M
$16.03 M(+33.2%)
$41.69 M(+74.2%)
Sep 2020
-
$12.04 M(-18.2%)
$23.93 M(+135.9%)
Jun 2020
-
$14.71 M(-1459.5%)
$10.14 M(-271.7%)
DateAnnualQuarterlyTTM
Mar 2020
-
-$1.08 M(-37.6%)
-$5.91 M(-3.0%)
Dec 2019
-$6.09 M(-0.8%)
-$1.74 M(-0.7%)
-$6.09 M(-2.0%)
Sep 2019
-
-$1.75 M(+30.0%)
-$6.22 M(+2.6%)
Jun 2019
-
-$1.34 M(+6.5%)
-$6.06 M(-0.5%)
Mar 2019
-
-$1.26 M(-32.2%)
-$6.09 M(-0.8%)
Dec 2018
-$6.14 M(-7.7%)
-$1.86 M(+16.9%)
-$6.14 M(+6.2%)
Sep 2018
-
-$1.59 M(+16.0%)
-$5.78 M(-28.3%)
Jun 2018
-
-$1.37 M(+4.7%)
-$8.07 M(+9.1%)
Mar 2018
-
-$1.31 M(-12.9%)
-$7.39 M(+11.2%)
Dec 2017
-$6.65 M(+293.9%)
-$1.50 M(-61.2%)
-$6.65 M(+19.0%)
Sep 2017
-
-$3.88 M(+453.3%)
-$5.59 M(+165.8%)
Jun 2017
-
-$701.00 K(+24.2%)
-$2.10 M(+17.3%)
Mar 2017
-
-$564.40 K(+26.9%)
-$1.79 M(-43.9%)
Dec 2016
-$1.69 M(-14.2%)
-$444.60 K(+13.3%)
-$3.20 M(+16.2%)
Sep 2016
-
-$392.40 K(+0.5%)
-$2.75 M(+16.6%)
Jun 2016
-
-$390.30 K(-80.2%)
-$2.36 M(+19.8%)
Mar 2016
-
-$1.97 M
-$1.97 M
Dec 2015
-$1.97 M
-
-

FAQ

  • What is Co-Diagnostics annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Co-Diagnostics?
  • What is Co-Diagnostics annual EBIT year-on-year change?
  • What is Co-Diagnostics quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Co-Diagnostics?
  • What is Co-Diagnostics quarterly EBIT year-on-year change?
  • What is Co-Diagnostics TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Co-Diagnostics?
  • What is Co-Diagnostics TTM EBIT year-on-year change?

What is Co-Diagnostics annual earnings before interest & taxes?

The current annual EBIT of CODX is -$42.71 M

What is the all time high annual EBIT for Co-Diagnostics?

Co-Diagnostics all-time high annual earnings before interest & taxes is $46.06 M

What is Co-Diagnostics annual EBIT year-on-year change?

Over the past year, CODX annual earnings before interest & taxes has changed by -$31.11 M (-268.43%)

What is Co-Diagnostics quarterly earnings before interest & taxes?

The current quarterly EBIT of CODX is -$10.23 M

What is the all time high quarterly EBIT for Co-Diagnostics?

Co-Diagnostics all-time high quarterly earnings before interest & taxes is $16.03 M

What is Co-Diagnostics quarterly EBIT year-on-year change?

Over the past year, CODX quarterly earnings before interest & taxes has changed by +$1.59 M (+13.45%)

What is Co-Diagnostics TTM earnings before interest & taxes?

The current TTM EBIT of CODX is -$40.00 M

What is the all time high TTM EBIT for Co-Diagnostics?

Co-Diagnostics all-time high TTM earnings before interest & taxes is $53.11 M

What is Co-Diagnostics TTM EBIT year-on-year change?

Over the past year, CODX TTM earnings before interest & taxes has changed by +$2.71 M (+6.34%)